Moser, J. C., Ahnert, J. R., Papadopoulos, K., Ofir-Rosenfeld, Y., Holz, J., Snyder, M., Hutchinson, M., McCaleb, K., Uryu, S., Raman, A., Anmangandla, A., Stengel, G., Martin, E. (2026). A subset analysis of clinical activity and pharmacodynamic biomarkers in patients with sarcomas in the phase 1 dose-escalation study of STC-15, a METTL3 inhibitor.. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2026.44.16_suppl.11548